ZMYM2 and myeloproliferative disorder: ZMYM2 (also known as ZnF198) is fused with the FGFR1 receptor tyrosine kinase in bone marrow cells from patients with an atypical myeloproliferative disease and its expression as a fusion with FGFR1 renders cells sensitive to UV irradiation (34).